Items stated in the management plan
Formulated| Item | Details |
|---|---|
| Plan name | 15th Medium-Term Management Plan |
| Plan period | Fiscal years 2026-2030 |
| Progress against the plan | Formulated |
| Sales Target | Not disclosed → At least ¥10 billion |
| Operating profit margin target | Not disclosed → At least 5% |
| Payout ratio / DOE policy | During the period covered by the 15th Medium-Term Management Plan, the Company will pay an interim dividend of ¥12 per share and a year-end dividend of ¥12 per share, for an annual dividend of ¥24 per share. It will consider maintaining stable dividends and implementing flexible shareholder return measures in line with earnings growth. |
| Self-assessment of PBR and share price | The Company aims to achieve a PBR (price-to-book ratio) of 1x at an early date and will strengthen its IR activities, improve capital efficiency, and promote dialogue with shareholders. |
| Total investment plan | Approximately ¥3.5 billion (5-year total) |
| Investment amount by sector | Field Installation of mass-production equipment for existing products / Investment amount Not disclosed, Field Investment in new product development / Investment amount Not disclosed |
| Segment target | Segment Optical Business / Sales target ¥2.2 billion / Actual results for the fiscal year ending March 2026 ¥2.2 billion, Segment Healthcare and life sciences business / Sales target ¥3.1 billion / Actual results for the fiscal year ending March 2026 ¥1.9 billion, Segment Functional business / Sales target ¥4.3 billion / Actual results for the fiscal year ending March 2026 ¥3.4 billion, Segment Telecommunications Business / Sales target ¥400 million / Actual results for the fiscal year ending March 2026 ¥350 million |
| Key initiatives | Pursue sustainable growth through wellness branding, Strengthen the ability and execution of proposals for shifting from OEM to ODM, under which the contracted manufacturer handles the process consistently from design through production, Integrate technologies and expertise across businesses, Develop business models through alliances with external partners, Establish a Business Strategy Department, Obtain ISO 15378 certification and pursue entry into overseas markets, Accelerate growth, including by expanding the Second Fukushima Plant and constructing a new plant, Advance development to expand market share in exterior lighting for automobiles and commercialize perceptual lighting, Establish a further expanded production system for rubber products used in table tennis rackets, Contribute to the promotion of DX in the agriculture and infrastructure sectors, Expand shareholder return measures, Initiatives related to well-being |
| Risks identified | A revenue structure in which automotive-related products account for more than approximately 50% of net sales, The accelerating shift to EVs in recent years, The semiconductor shortage, Various geopolitical risks, Sluggish margin growth resulting from new investments and higher fixed costs, A decline in margins resulting from the burden of upfront investments |
| Publication date | 14 May 2026 |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In businesses with long development cycles, such as products for the healthcare field, a conventional 3-year plan may show progress only through the stage at which planning and design have begun. The Company therefore adopted a 5-year plan to pursue its initiatives with an eye toward the goals for 2030 and beyond. The plan is also intended to resolve issues including dependence on specific businesses, dependence on automotive-related sales, and sluggish margin growth resulting from new investments and higher fixed costs, thereby achieving sustainable growth.